Is Alphabet an Undervalued Growth Stock to Buy?
Alphabet (NASDAQ:GOOGL) is easily one of the most successful companies…
Sell
46
TOI Quote, Financials, Valuation and Earnings
Last price:
$0.21
Seasonality move
:
-6.55%
Day range:
$0.20 - $0.22
52-week range:
$0.13 - $2.50
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.04x
P/B ratio:
1.00x
Volume:
577.4K
Avg. volume:
3.4M
1-year change:
-88.4%
Market cap:
$15.4M
Revenue:
$324.2M
EPS (TTM):
-$0.78
Earnings Data
Next earnings date for TOI
Mar 27
2025
Most recent earnings per share
-$0.18
Missed by $0.18
(Nov 13/2024)
Consensus Estimate
--
(Nov 13/2024)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
TOI Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 11/13/2024 | Q3 | -- | $99.9M | -$0.18 | -- | -- |
| 08/13/2024 | Q2 | $103.3M | $98.6M | -$0.17 | -$0.10 | -$0.07 |
| 05/14/2024 | Q1 | $95.2M | $94.7M | -$0.22 | -$0.12 | -$0.10 |
| 03/27/2024 | Q4 | $82M | $85.8M | -$0.21 | -$0.11 | -$0.10 |
| 11/08/2023 | Q3 | -- | -- | -$0.19 | -$0.13 | -$0.06 |
| 08/08/2023 | Q2 | -- | -- | -$0.19 | -$0.17 | -$0.02 |
| 05/10/2023 | Q1 | -- | -- | -$0.33 | -- | -- |
| 03/09/2023 | Q4 | -- | -- | -$0.15 | -$0.20 | $0.05 |
| 11/09/2022 | Q3 | -- | -- | -$0.17 | -$0.18 | $0.01 |
| 08/09/2022 | Q2 | -- | -- | -$0.06 | -- | -- |
| 05/11/2022 | Q1 | -- | -- | $0.21 | -- | -- |
| 03/10/2022 | Q4 | -- | -- | -$0.15 | -- | -- |
| 09/30/2021 | Q3 | -- | -- | -$0.04 | -- | -- |
| 06/30/2021 | Q2 | -- | -- | $0.05 | -- | -- |
| 03/31/2021 | Q1 | -- | -- | -$0.02 | -- | -- |
| 12/31/2020 | Q4 | -- | -- | -$0.13 | -- | -- |
| 09/30/2020 | Q3 | -- | -- | -$0.08 | -- | -- |
| 06/30/2020 | Q2 | -- | -- | $0.02 | -- | -- |
| 12/31/2018 | Q4 | -- | -- | -$0.03 | -- | -- |
The Oncology Institute Earnings Questions
-
How Much did The Oncology Institute Generate in Revenue Last Quarter?
The Oncology Institute reported $99.9M worth of top line sales in its most recent quarter.
-
Did The Oncology Institute Beat Earnings Last Quarter?
The Oncology Institute announced earnings per share of -$0.18 which represents a miss of analyst forecast a -- per share.
-
Is The Oncology Institute Profitable?
The Oncology Institute reported $14.4M that represents $0.19 per share over the last quarter.
-
What is the Analyst Consensus for The Oncology Institute EPS Next Year?
The Oncology Institute's earnings are forecast to decrease from -$0.92 per share to -$0.51 per share next year representing a decrease of -54.35%.
-
When is The Oncology Institute's Earnings Date?
The Oncology Institute's next earnings date is March 27, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Tesla Going to Buy Uber?
Tesla has always been in the habit of making large,…
NVIDIA vs Broadcom Stock: Which Is Best?
If you want to invest in an AI-leading tech company,…
Stock Ideas
Buy
65
Is AAPL Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 42x
Buy
57
Is NVDA Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 117x
Buy
53
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 37x
Alerts
Sell
40
MSTR alert for Dec 24
MicroStrategy [MSTR] is up 7.46% over the past day.
Sell
26
NUTX alert for Dec 24
Nutex Health [NUTX] is down 0.76% over the past day.
Sell
48
VRNA alert for Dec 24
Verona Pharma PLC [VRNA] is down 0.62% over the past day.
